Inserm Researcher in the field of Cardiovascular Research, currently focusing on therapeutic angiogenesis with polymer-based targeted growth factor delivery.
PhD in Tumor Biology (Pr Yihai Cao, Karolinska Institutet, Sweden), and expertise in Adipose tissue angiogenesis. Postdoc at UCLA (Pr Lily Wu) in molecular imaging and tumor lymphangiogenesis field.
Member of European Vascular Biology Organisation, French society for Cardiovascular Research, French society for Angiogenesis Research.
Associate Professor of Anesthesiology at University of Rochester Medical Center. PhD in Biochemistry from Cambridge University (UK) and post-doctoral training at the University of Alabama at Birmingham. Research program in mitochondria, cardiac ischemia, and cardioprotective therapies.
2002 Radiology Staff at the Erasmus University Medical Center (EMC) of Rotterdam, NL
2005 PhD in Cardiac Imaging at the EMC, Rotterdam, NL
2006-2011 Head of Cardiac Imaging at the Academic Hospital, Parma, IT
2011-2015 Head of Cardiac Imaging at the Giovanni XXIII Clinic, Monastier, IT
2012 UHD-Associate Professor of Radiology at EMC, Rotterdam, NL
2015 Director CT Core Lab at Montréal Heart Institute/Université de Montréal, Canada
2015 Associate Professor of Radiology at Montréal Heart Institute/Université de Montréal, Canada
Author of ~900 publications: 12 books, 86 book chapters, 347 scientific papers, >260 oral presentations, and >260 posters (h-index = 59; IF >1500).
Professor and Chair of Department of Preventive Medicine and Epidemiology at Loyola University Medical School, Chicago, IL. Preview editor of journal Ethnicity and Disease. Recipient of a 'MERIT' Award from the NIH in 2002; member of National Advisory Council and NHGRI, NIH.
Director of the Center for Human Nutrition. Member of the American Society for Clinical Investigation, the American Association of Physicians, and the National Academies of Sciences (Institute of Medicine).
The overall aim of my research is to develop a mechanistic understanding of the pathogenesis of accelerated cardiac and renal dysfunction during cardio-renal syndrome. Thus, we seek to identify novel mechanisms of cardiac and renal injury in order to aid and improve diagnostic, therapeutic, and preventive strategies in this high-risk population of patients. One of the primary scientific objectives of my laboratory is to understand the pathophysiology whereby endogenous counter-regulatory mechanisms become maladaptive and contribute to disease progression in patients with cardio-renal syndrome.
Assistant Professor of Cardiovascular Sciences at Houston Methodist Research Institute and Assistant Professor of Cell and Developmental Biology in the Department of Cardiothoracic Surgery at Weill Cornell Medical College of Cornell University. Dr. Prasanna earned his BVSc (DVM) degree with honors from Bangalore Veterinary College, India and his Masters and PhD in Veterinary Pathology from Indian Veterinary Research Institute (India's premier institute for Veterinary Research). He completed his postdoctoral training at Feinberg Cardiovascular Research Institute. Before joining Houston Methodist Research Institute, he served as Assistant Professor at Northwestern University.
The overall research theme of the Prasanna Laboratory is to understand the mechanisms of cardiovascular diseases that will aid in developing innovative new therapies and translate that information to the clinics to treat heart disease and improve lives of patients. The Prasanna Laboratory in Department of Cardiovascular Sciences and Center for Cardiovascular Regeneration at the Houston Methodist Research Institute (HMRI) is located on Texas Medical Center Campus.
1997: PhD Cancer Research Centre of the Russian Academy of Medical Sciences, Moscow.
1997-2001: Postdoc at the University of Regensburg
2001-2007: Junior group leader/PI and lecturer, University of Heidelberg.
2007- 2010:Senior group leader/PI and senior lecturer, University of Heidelberg
2010-2013: Professor, head of the Lab for Cellular and Molecular Biology of Innate Immunity;
2013-permanent: Professor, head of Department for Innate Immunity and Tolerance, University of Heidelberg.
Research Fellow, The University of Adelaide.
Cadiac Electrophysiologist, Royal Adelaide Hospital.
Dr Lau's PhD was focussed on the effect of hypertension on the development of atrial arrhythmias. He is recognized both nationally and internationally for his research in the area of arrhythmia substrates. To date, Dennis has co-authored more than 100 peer-reviewed publications and book chapters. His interests in atrial fibrillation include risk factor management, substrate mapping, signal analysis and mechanistic studies. He is a clinician scientist dedicated to combine preclinical studies and clinical research in the field of heart rhythm disorders.
Professor of Human Genetics, Medicine, and Microbiology,Immunology and Molecular Genetics, University of California, Los Angeles. Associate Editor, Journal of Lipid Research. Recipient of 2008 American Heart Association Duff Award and2009 NAVBO Benditt Award.
2003-2008: M.D. Third Military Medical University
2008-2010: M.Sc. Third Military Medical University
2010-2013: Residency/Fellowship in Cardiology, Chengdu Military General Hospital
2014-Present: Postdoctoral Research at Mayo Clinic, Houston Methodist, and University of Texas Health Science Center at Houston
Scientific Director of the Research Hospital Cà Granda Foundation in Milan. Awards include the Murray Thelin Award; the Robert Grant Medal, the Ham-Wasserman Lecture Award, and the Jean Bernard Award. Former President of the International Society for Thrombosis and Haemostasis and Former Editor-in-Chief of the Journal Thrombosis and Haemostasis. Currently Editor-in-Chief of the European Journal of Internal Medicine.